北京中医药大学学报第30卷第8期2007年8月JournalofBeijlngUniversityofTraditionalChineseMedicineV01.30No.8Aug.2007降糖明日胶囊治疗糖尿病视网膜病变临床观察8支楠1廉海红1马小丽1王津津2陈青红1何秀芹1鹿庆2(1首都医科犬学附属北京同仁医院传统医学科北京100730;2北京市眼科研究所)摘要:目的观察降糖明目胶囊治疗糖尿病性视网膜病变(DR)的临床疗效。方法选择60例DR患者作为治疗组,给予降糖明日腋囊治疗6个月后对治疗前后中医证候、血糖、安垒性等多种指标进行对比;同时选择60侧DR患者作为对照组,服用怡开6个月后与治疗组在眼底视网膜病变方面进行对比。结果治疗组可有效改善中医证候,治疗前后积分对比(P<0.01);眼底视网膜病变的改善治疗组优于对照组(P<0.01);治疗组血糖降低,治疗前后对比(P<0.01);治疗组治疗前后安全性指标均有改善,且服药期间无明显不良反应。结论降糖明日胶囊可从整体上改善DR患者临床症状、改善眼底视网膜病变、降低血糖,并且有良好的安全性。关键词:糖尿病视网膜病变;降糖明日胶囊;滋补肝肾;活血化瘀中图分类号:1/276.774.1TreatmentofdiabeticretinopathywithJiangtangmingmuCapsulesZHINan,LIANHai-hong,MAXiao-li,eta1.(BeijingTongrenHospital,CapitalUniversityofMedicalSciences,Beijing100730)Abstract:ObjectiveToobservethecurativeeffectofJian粤angrningmuCapsules0ndiabeticretinopathy(DR).MethodThetreatmentgroup,including60patientswithDR,wastreatedwithJiangtangreingmuCapsulesfor6months,andthentheindexes,includingTCMsyndromemanifestations,bloodsugarlevelandsecurityindexes,werecomparedbeforeandafterthetreatment.Thecontrolgroup,including60patients,wastreatedwithYikaifor6monthsandthenitwascomparedwiththetreatmentgroupinfundusretinopadiy.ResultInthetreatmentgrouptheTCMsyndromemanifestitionswererelieved.thecomparisonofintegralbeforeandafterthetreatmentwasP<0.01.ThereliefoffundusrefiuopathyinthetreatmentgroupWaSbetterthanthatofthecontrolgroup(P